A1,
A2,
B,
C1,
C2,
D,
E,
F,
G-H,
I-K,
L,
M,
N,
O,
P1,
P2,
Q-R,
S,
T,
U-V,
W-Z
Seldane D Indications, Dosage, Storage, Stability - Pseudoephedrine Hydrochloride; Terfenadine
Seldane D Indications, Dosage, Storage, Stability - Pseudoephedrine Hydrochloride; Terfenadine
INDICATIONS
Seldane-D is indicated for the relief
of symptoms associated with seasonal allergic rhinitis
such as sneezing, rhinorrhea,
pruritus, lacrimation,
and nasal congestion.
It should be administered when both the antihistaminic properties
of Seldane (terfenadine) and the nasal
decongestant activity
of pseudoephedrine hydrochloride
are desired.
Seldane-D has not been studied for effectiveness
in relieving symptoms of the common cold.
DOSAGE AND ADMINISTRATION
Adults and pediatric
patients 12 years and older: one tablet
swallowed whole, morning and night.
USE OF DOSES IN EXCESS OF ONE TABLET B.I.D. IS NOT RECOMMENDED
BECAUSE OF THE INCREASED POTENTIAL FOR QT INTERVAL PROLONGATION
AND ADVERSE CARDIAC EVENTS. USE OF SELDANE-D IN PATIENTS WITH SIGNIFICANT
HEPATIC DYSFUNCTION AND IN PATIENTS TAKING KETOCONAZOLE, ITRACONAZOLE,
CLARITHROMYCIN, ERYTHROMYCIN, OR TROLEANDOMYCIN IS CONTRAINDICATED.
HOW SUPPLIED
(Removed
from market 1998)
Seldane-D Tablets containing 60 mg
of terfenadine and 10 mg of pseudoephedrine hydrochloride
in an outer press-coat for immediate release and 110 mg
of pseudoephedrine hydrochloride
in an extended- release core.
Tablets are white to
off-white, biconvex
capsule-shaped; debossed "Seldane-D".
Store at controlled room
temperature (59-86°F)
(15-30°C). Protect from moisture.
top
